Proportion of isolates with decreased susceptibility or resistance in Peru
Peru: Proportion of isolates with decreased susceptibility or resistance was 0 in 2020. ◆ Volatile
Latest (2020)
0
World rank
13th
of 52 countries
All-time high
2.38
in 2016
All-time low
0
in 2009
Years of data
7
2009–2020
Proportion of isolates with decreased susceptibility or resistance in Peru, 2009–2020
Source: World Health Organization, Global Health Observatory.
Analysis
Peru recorded 0 for proportion of isolates with decreased susceptibility or resistance in 2020. That is the lowest value across all 7 years on record.
Over the whole period, proportion of isolates with decreased susceptibility or resistance in Peru peaked at 2.38 in 2016 and was at its lowest, 0, in 2009.
Peru ranks 13th of 52 countries on this measure, in the top quarter.
Proportion of isolates with decreased susceptibility or resistance in Peru, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 0 | — |
| 2014 | 0 | — |
| 2015 | 0 | — |
| 2016 | 2.38 | — |
| 2017 | 0 | -100.0% |
| 2018 | 0 | — |
| 2020 | 0 | — |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0 | 0 | 0 | 1 |
| 2010s | 0.4762 | 0 | 2.38 | 5 |
| 2020s | 0 | 0 | 0 | 1 |
Countries ranked near Peru
- 10 Belgium 0.6 compare
- 11 New Zealand 0.1 compare
- 12 Australia 0.01 compare
- 13 Korea 0 compare
- 13 Argentina 0 compare
- 13 Croatia 0
- 13 Pakistan 0 compare
- 13 Ireland 0 compare
- 13 Chile 0
- 13 Poland 0
- 13 Latvia 0
- 13 Slovenia 0 compare
- 13 Malta 0
- 13 Thailand 0 compare
- 13 United Kingdom of Great Britain and Northern Ireland 0
- 13 Colombia 0
- 13 Cyprus 0
- 13 Spain 0 compare
- 13 United States of America 0 compare
- 13 Paraguay 0
- 13 Belarus 0
- 13 Philippines 0 compare
- 13 Slovakia 0
- 13 Sweden 0
- 13 Greece 0 compare
- 13 France 0
- 13 Denmark 0
- 13 South Africa 0
- 13 Norway 0
- 13 India 0 compare
- 13 Dominican Republic 0
- 13 Austria 0 compare
- 13 Côte d'Ivoire 0
- 13 Germany 0 compare
- 13 Hungary 0
- 13 Iceland 0
- 13 Sri Lanka 0
- 13 Italy 0
- 13 Panama 0
- 13 Portugal 0
- 13 Netherlands 0
- 13 Estonia 0
More health data for Peru
- Un projection of annual infant deaths, annual growth rate -1.88 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5045 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,235 deaths per 1,000 people (2090)
- Number of infants who die before age 1 782 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate -0.3081 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.038 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.302 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is proportion of isolates with decreased susceptibility or resistance in Peru?
- Proportion of isolates with decreased susceptibility or resistance in Peru was 0 in 2020, according to World Health Organization, Global Health Observatory.
- What is the highest proportion of isolates with decreased susceptibility or resistance recorded in Peru?
- The highest recorded value was 2.38 in 2016.
- What is the lowest proportion of isolates with decreased susceptibility or resistance recorded in Peru?
- The lowest recorded value was 0 in 2009.
- How does Peru rank for proportion of isolates with decreased susceptibility or resistance?
- Peru ranks 13th out of 52 countries with data for 2020.
- Where does this Peru data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 7 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).